The controversy surrounding hydroxychloroquine's potential in treating COVID-19 has sparked debates among healthcare professionals, researchers, and policymakers worldwide.
plaquenil 200mg Initial excitement stemmed from in vitro studies suggesting its antiviral properties against SARS-CoV-2, the virus causing COVID-19. However, subsequent clinical trials have yielded inconclusive or conflicting results, raising questions about its efficacy and safety in clinical settings.